Mesoblast | MSB - Umsatzkosten

Aktienkurs
2.12
Täglich Wechseln
-0.10 -4.50%
Monatlich
-1.85%
Jährlich
12.77%
Q2 Prognose
2.15




Umsatzkosten Veränderung Datum
Avita Medical AUD 3.3M 166K 2025-12
Clinuvel Pharmaceuticals AUD 2.64M 1.06M 2025-12
Cochlear AUD 319.2M 160.35M 2025-12
CSL USD 3.87B 2.08B 2025-12
Pacific Edge NZD 280K 0 2024-03
Paradigm Biopharmaceuticals AUD 4.5K 2.62K 2025-12
Ramsay Health Care AUD 3.05B 78.7M 2025-12
Sonic Healthcare AUD 751.66M 801.13M 2024-12
Starpharma Holdings AUD 417K 459K 2025-12
Telix Pharmaceuticals AUD 221.36M 20.78M 2025-12